Trials / Not Yet Recruiting
Not Yet RecruitingNCT07254208
A Long-term Observational Study in Participants Who Have Received PBGENE-HBV
A Long-term Observational Study in Participants Who Have Received PBGENE-HBV, an In Vivo Gene Editing Investigational Product, in a Prior Clinical Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (estimated)
- Sponsor
- Precision BioSciences, Inc. · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Participants who received at least one dose of PBGENE-HBV will be enrolled in this LTFU study.
Detailed description
This is a LTFU observational study designed to evaluate the safety of PBGENE-HBV in participants previously exposed to PBGENE-HBV. This study protocol does not include administration of PBGENE-HBV.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | PBGENE-HBV | PBGENE-HBV is the investigational product administered in the parent study. This LTFU study is non-interventional; no investigational product given. |
Timeline
- Start date
- 2025-12-25
- Primary completion
- 2040-01-01
- Completion
- 2040-06-01
- First posted
- 2025-11-28
- Last updated
- 2025-11-28
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07254208. Inclusion in this directory is not an endorsement.